Expert: Pfizer Requests the Approval of COVID-19 Vaccine for Ages 5 to 11
October 8th 2021Anna Legreid-Dopp, PharmD, Senior Director of Clinical Guidelines and Quality Improvement at the American Society of Health-System Pharmacists discusses Pfizer’s request to approve their COVID-19 vaccine for children 5 to 11.